Porton and EVA Pharma Partner to Expand CAR T-Cell Therapy Access
June 26, 2025
Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and